Human ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection

Human ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection

The current pandemic originated by SARS-CoV-2 causes an unprecedented health crisis. The medical world has found itself helpless in the face of this virus, having to deal with the absence of specific effective treatment.... read more

Is chloroquine or hydroxychloroquine useful in treating people with COVID-19, or in preventing infection in people who have been exposed to the virus?

Is chloroquine or hydroxychloroquine useful in treating people with COVID-19, or in preventing infection in people who have been exposed to the virus?

COVID-19 is an infectious respiratory disease caused by a coronavirus called SARS-CoV-2. If the infection becomes severe, people may need intensive care and support in hospital, including mechanical ventilation. Drugs... read more

Barotrauma in Mechanically-ventilated Patients with COVID-2019

Barotrauma in Mechanically-ventilated Patients with COVID-2019

Within the limits of a survey, patients with COVID-19 might be at high risk for barotrauma during invasive (and allegedly lung-protective) mechanical ventilation. The response rate was 38/61 (62%). The incidence of... read more

Temporal development and neutralising potential of antibodies against SARS-CoV-2 in hospitalised COVID-19 patients

Temporal development and neutralising potential of antibodies against SARS-CoV-2 in hospitalised COVID-19 patients

Antibody responses are important in the control of viral respiratory infection in the human host. What is not clear for SARS-CoV-2 is how rapidly this response occurs, or when antibodies with protective capability evolve.... read more

RECOVERY trial shows tocilizumab reduces deaths in patients hospitalised with COVID-19

RECOVERY trial shows tocilizumab reduces deaths in patients hospitalised with COVID-19

The NIHR-supported RECOVERY trial has shown that tocilizumab - an anti-inflammatory rheumatoid arthritis treatment - reduces the risk of death for hospitalised patients with severe COVID-19. Researchers also found that... read more

Surviving Sepsis Campaign Guidelines on the Management of Adults with COVID-19 in the ICU

Surviving Sepsis Campaign Guidelines on the Management of Adults with COVID-19 in the ICU

The Surviving Sepsis Campaign Coronavirus Disease 2019 panel issued several recommendations to guide healthcare professionals caring for adults with critical or severe coronavirus disease 2019 in the ICU. Based on a living... read more

COVID-19 and VILI: Mechanical Power Measurement

COVID-19 and VILI: Mechanical Power Measurement

The COVID-19 pandemic has increased the need for a bedside tool for lung mechanics assessment and ventilator-induced lung injury (VILI) monitoring. Mechanical power is a unifying concept including all the components which... read more

COVID-19 Awake Proning – All Hype?

COVID-19 Awake Proning – All Hype?

In this prospective meta-analysis of observational studies of patients with acute hypoxemic respiratory failure due to COVID-19, APP did not result in lower intubation or mortality rates, despite reported improvements in... read more

Mediastinal lymphadenopathy may predict 30-day mortality in COVID-19 patients

Mediastinal lymphadenopathy may predict 30-day mortality in COVID-19 patients

Along with older age and consolidation pattern,enlarged mediastinal lymphadenopathy was found to be an independent predictor of 30-day mortality in patients with COVID-19. Although enlarged mediastinal lymphadenopathy... read more

COVID-19: Clinical manifestations of blood cell parameters and inflammatory factors

COVID-19: Clinical manifestations of blood cell parameters and inflammatory factors

CRP and Lymphocyte count (LYM#) showed strong correlation with disease progression, suggesting that these parameters could be used to monitor changes in patient condition. 92 patients with confirmed COVID-19 at Jingzhou... read more

Covid PPE: How healthcare workers came to feel expendable

Covid PPE: How healthcare workers came to feel expendable

Over the course of the coronavirus pandemic, there have been hundreds of deaths among healthcare staff from Covid and many thousands off sick or self-isolating, but many hospital staff say they still don't feel properly protected... read more

Consequences of COVID-19 in discharged patients

Consequences of COVID-19 in discharged patients

At 6 months after acute infection, COVID-19 survivors were mainly troubled with fatigue or muscle weakness, sleep difficulties, and anxiety or depression. Patients who were more severely ill during their hospital stay... read more

FDA Limits Use of Convalescent Plasma as COVID-19 Treatment

FDA Limits Use of Convalescent Plasma as COVID-19 Treatment

The Food and Drug Administration (FDA) is scaling back its authorization of the use of convalescent blood-plasma for COVID-19 patients in an effort to guide physicians who have faced a confusing thicket of data about the... read more

Post-COVID Syndrome or Post-Sepsis Syndrome?

Post-COVID Syndrome or Post-Sepsis Syndrome?

Since the initial outbreak of COVID-19, there have been reports of many people living with a new condition named post-COVID syndrome. These people are young and old, and they experience symptoms long after the infection has... read more